SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : MEDX ... anybody following? -- Ignore unavailable to you. Want to Upgrade?

To: rkrw who wrote (1184)12/15/2005 9:54:02 AM
From: tom pope  Read Replies (2) | Respond to of 2240
 
Does CEGE still have the 6MM shares of ABGX, does any one know? It seems to be participating in the buyout euphoria.



To: rkrw who wrote (1184)12/16/2005 9:03:14 AM
From: IRWIN JAMES FRANKEL  Read Replies (1) | Respond to of 2240
 
>>I think medx should be up because their big humab license competitor just disappeared.

As I recall, ABGX and MEDX cross licensed their mab patent estates (or part of them).

That suggests to me that with ABGX gone there could be a scramble to buy MEDX.

ij


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News